Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Conserved oligomeric Golgi complex subunit 3 (COG3) is an essential subunit of the conserved oligomeric Golgi (COG) complex, a multiprotein complex comprising eight subunits that is required for normal Golgi morphology and function. COG3 participates in the tethering of retrograde intra-Golgi vesicles, a key step prior to their fusion with Golgi cisternae, and is crucial for maintaining Golgi organization, dynamics, and appropriate protein glycosylation. Disruption of COG3 or the larger COG complex leads to Golgi fragmentation and multiple defects in protein glycosylation, underlying congenital disorders such as congenital disorder of glycosylation type IIbB. COG3 interacts functionally with other COG complex subunits to regulate vesicular trafficking between the ER and Golgi, and is not considered a classical drug target such as a receptor, enzyme, or transporter, but rather is a key component of the vesicle tethering apparatus within the Golgi apparatus[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Conserved oligomeric Golgi complex subunit 3 (COG3).